Search
Umeclidinium
go.drugbank.com/drugs/DB09076ApprovedInvestigational[A7718,A7714] Umeclidinium was approved by the FDA in April 2014 under the brand name Incruse Ellipta as a standalone product. … Umeclidinium is a long-acting muscarinic antagonist (LAMA) used as a maintenance treatment for symptoms of chronic obstructive pulmonary disease (COPD).
Synonyms: UmeclidiniumSalts: Umeclidinium bromideVilanterol
go.drugbank.com/drugs/DB09082ApprovedInvestigationalwith both [fluticasone furoate] and [umeclidinium bromide] under the trade name TRELEGY ELLIPTA. … [A7738,A259961] Vilanterol is approved for use in several combination products such as with [fluticasone furoate] under the tradename BREO ELLIPTA, with [umeclidinium bromide] as ANORO ELLIPTA, and
Mixtures: Umeclidinium and Vilanterol ElliptaCategories: vilanterol and umeclidinium bromide, vilanterol, umeclidinium bromide and fluticasone furoateFluticasone furoate
go.drugbank.com/drugs/DB08906ApprovedInvestigationalFluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications[FDA Label] . Fluticasone furoate was first approved in 2007 .
Categories: vilanterol, umeclidinium bromide and fluticasone furoateChronic Obstructive Pulmonary Disease (COPD)
go.drugbank.com/conditions/DBCOND0031289Asthma
go.drugbank.com/conditions/DBCOND0013565Drugs: Albuterol · Ambrosia artemisiifolia pollen · Aminophylline · Arformoterol · Beclomethasone dipropionate · Budesonide +39 more